Markets:

Overview

News

Currencies

International

Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

3.650 -0.330 (-8.29%)

Streaming Delayed Price Updated: 3:53 PM EDT, May 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 Next >

Exagen (XGN) Q1 2026 Earnings Transcript ↗

Today 14:16 EDT

Exagen (XGN) Q1 2026 Earnings Transcript

Via The Motley Fool

Exagen Q1 Earnings Call Highlights ↗

May 11, 2026

Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician...

Via MarketBeat

Topics Earnings

Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally ↗

May 11, 2026

Via Chartmill

Topics Earnings

Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗

March 10, 2026

Via Chartmill

Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗

November 04, 2025

Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline.

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Exagen Stock ↗

September 11, 2025

Via Benzinga

What Analysts Are Saying About Exagen Stock ↗

July 30, 2025

Via Benzinga

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 27, 2025

Via Benzinga

Demystifying Exagen: Insights From 5 Analyst Reviews ↗

October 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 29, 2025

Via Benzinga

Exagen Q2 Revenue Jumps 14 Percent ↗

July 29, 2025

Via The Motley Fool

Topics Intellectual Property

Exagen Inc (NASDAQ:XGN) Surpasses Revenue Estimates in Q2 2025 Despite Wider Loss, Shares Rally in Pre-Market Trading ↗

July 29, 2025

Exagen Inc (XGN) beats Q2 2025 revenue estimates with $17.2M but posts wider loss. Stock jumps 6.77% pre-market as investors focus on growth potential.

Via Chartmill

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Outlook For Exagen ↗

March 15, 2024

Via Benzinga

Top movers in Thursday's pre-market session ↗

May 08, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 08, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

May 07, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

February 04, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Market Mayhem Winners: What Stocks Are Up Today? ↗

August 05, 2024

What stocks are up today? It’s a natural question following the implosion of the global markets and the answer might surprise you.

Via InvestorPlace

XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024 ↗

August 05, 2024

XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024 ↗

May 13, 2024

XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023 ↗

March 18, 2024

XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 18, 2024 ↗

March 18, 2024

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 04, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.